BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12768076)

  • 1. Azathioprine hypersensitivity: report of two cases and review of the literature.
    Sinico RA; Sabadini E; Borlandelli S; Cosci P; Di Toma L; Imbasciati E
    J Nephrol; 2003; 16(2):272-6. PubMed ID: 12768076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New therapeutic strategies in ANCA-associated systemic vasculitis].
    Ruiz FL; Bart PA
    Rev Med Suisse; 2005 Jan; 1(1):19-23. PubMed ID: 15773192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of azathioprine hypersensitivity after administration of its active metabolite 6-mercaptopurine.
    Schmitt K; Pfeiffer U; Stiehrle HE; Thuermann PA
    Acta Derm Venereol; 2000; 80(2):147-8. PubMed ID: 10877141
    [No Abstract]   [Full Text] [Related]  

  • 4. The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome.
    Bidinger JJ; Sky K; Battafarano DF; Henning JS
    J Am Acad Dermatol; 2011 Jul; 65(1):184-91. PubMed ID: 21496951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease.
    de Fonclare AL; Khosrotehrani K; Aractingi S; Duriez P; Cosnes J; Beaugerie L
    Arch Dermatol; 2007 Jun; 143(6):744-8. PubMed ID: 17576940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of direct immunofluorescence test in cutaneous leukocytoclastic vasculitis.
    Sais G; Vidaller A
    Int J Dermatol; 2005 Nov; 44(11):970-1; author reply 971. PubMed ID: 16336539
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
    Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
    Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials.
    Vanková Z; Ríhová Z; Jancová E; Rysavá R; Merta M; Tesar V
    Prague Med Rep; 2006; 107(2):199-212. PubMed ID: 17066740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
    Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
    Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine hypersensitivity syndrome: report of two cases.
    McKenzie T; Dheda S; Mantha M; Larsen C
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34011657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Jourde N; Mancini J; Chiche L
    N Engl J Med; 2009 Mar; 360(13):1358; author reply 1359. PubMed ID: 19321874
    [No Abstract]   [Full Text] [Related]  

  • 19. Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management.
    Aloush V; Litinsky I; Caspi D; Elkayam O
    Semin Arthritis Rheum; 2006 Aug; 36(1):4-9. PubMed ID: 16887463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.